2024年3月8日,Nat Rev Drug Discov发表文章Top companies and drugs by sales in 2023,介绍了2023年销售额最高的公司和药品。 正如人们所预料的那样,2023年制药行业的排名榜发生了变化。辉瑞因其COVID-19疫苗Comirnaty的巨大销售额而连续多年稳居榜首,但后来却一落千丈,由强生取而代之(图1a)。这一新的市...
2024年3月8日,Nat Rev Drug Discov发表文章Top companies and drugs by sales in 2023,介绍了2023年销售额最高的公司和药品。正如人们所预料的那样,2023年制药行业的排名榜发生了变化。辉瑞因其COVID-19疫苗Comirnaty的巨大销售额而连续多年稳居榜首,但后来却一落千丈,由强生取而代之(图1a)。这一新的市场领导...
2024年3月8日,Nat Rev Drug Discov发表文章Top companies and drugs by sales in 2023,介绍了2023年销售额最高的公司和药品。 以往年度的回顾文章参见 Nat Rev Drug Discov|2022年销售额排名Top10的制药公司和药品 Nat Rev Drug Discov|2021年制药公司和药物的销售额Top10 正如人们所预料的那样,2023年...
Companies Research and development Miscellaneous The most important statistics U.S. total medicine spending 2002-2023 Leading therapy areas by pharma revenue in the U.S. 2023 Top pharma products by prescriptions U.S. 2022 U.S. top prescribed drugs based on sales 2023 U.S. biopharmaceutical expor...
Over the past few years, the tussle for biopharma's biggest company by sales has largely been contested by Novartis and Pfizer; but a winning streak of blockbuster launches, including the multiple sclerosis drug Ocrevus (ocrelizumab) and PD-L1 inhibitor Tecentriq (atezolizumab) have helped the ...
While the global sales rankings of Big Pharma's superstar drugs naturally feature the biggest names in the business, new meds often pop up or old drugs exit the scene. And the moves within the list from year to year illustrate many of the trends shaping pharma on a daily basis. The top...
Pharmaceutical market: worldwide revenue 2001-2023 Top global pharmaceutical companies based on pharma revenue 2022 Top 10 biotech and pharmaceutical companies based on market cap 2024 Projected top pharmaceutical companies based on sales 2023 Top drugs based on projected 2024 global sales ...
Explore the top pharmaceutical companies of 2020 Pharmaceutical Technology. Discover their innovations, revenue, and impact on healthcare.
The pharmaceutical industry continues to generate stellar growth and was estimated to be worth an impressive US$1.6 trillion in 2023. Despite disruptions caused by the Covid-19 pandemic in recent years and rising research and development costs globally, pharmaceutical companies have remained agile. ...
Forecasting drug sales is a tricky business; just ask any biopharma CEO who has overpromised and underdelivered. The people who make it their business know that very well, and they update their numbers with every big shift in the market and every surpris